EXPRESSION OF TYPE-IV COLLAGEN-DEGRADING ACTIVITY DURING EARLY EMBRYONAL DEVELOPMENT IN THE SEA-URCHIN AND THE ARRESTING EFFECTS OF COLLAGEN-SYNTHESIS INHIBITORS ON EMBRYOGENESIS
G. Karakiulakis et al., EXPRESSION OF TYPE-IV COLLAGEN-DEGRADING ACTIVITY DURING EARLY EMBRYONAL DEVELOPMENT IN THE SEA-URCHIN AND THE ARRESTING EFFECTS OF COLLAGEN-SYNTHESIS INHIBITORS ON EMBRYOGENESIS, Journal of cellular biochemistry, 52(1), 1993, pp. 92-106
Type IV collagen-degrading activity was expressed in homogenates of Ly
techinus pictus embryos during embryogenesis. Activity was concentrate
d 1,600-fold by ammonium sulfate fractionation, ion exchange, and gel
chromatography and could not be activated further upon trypsin or orga
nomercurial treatment. This enzyme activity could also degrade gelatin
but had no affinity for type I, III, and V collagens. Activity was in
hibited by addition of excess type IV collagen or gelatin, but was una
ffected by addition of excess amounts of non-collagenous proteins of t
he extracellular matrix. Chelators such as 1,10-phenanthroline or Na2E
DTA reduced activity to control levels. Inhibitors of plasmin and of s
erine and thiol proteases were without effect. Type IV collagen-degrad
ing activity first became apparent at the stage of early mesenchyme bl
astula. It then increased by a small increment and remained stable up
to the stage of late mesenchyme blastula, coinciding with first detect
ion of collagen synthesis and the appearance of the archenteron. There
after, a sharp increase in activity was observed, concurrently with re
modelling of the archenteron. Maximum activity was attained at prism s
tage and was retained throughout to pluteus-larva stage. The specific
inhibitors of collagen biosynthesis 8,9-dihydroxy-7-methyl-benzo[b]qui
nolizinium bromide and tricyclodecane-9-yl xanthate arrested sea urchi
n embryo development at early blastula, prevented the invagination of
the archenteron, and reverted the expression of type IV collagen-degra
ding activity to non-detectable levels. Removal of the inhibitors allo
wed embryos to gastrulate and express type IV collagen-degrading activ
ity.